ArticleJournal of clinical microbiology2012
Echinocandin resistance in two Candida haemulonii isolates from pediatric patients.
Article in Journal of clinical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Alexidine as a Potent Antifungal Agent AgainstACS omega · 2025Article
- The multidrug-resistantCurrent research in microbial sciences · 2025Review
- Climatic and endothermic thermal stress adaptation may be a major driver of emerging and emergent multidrug resistant fungi.Frontiers in microbiology · 2025Review
- Identification and antifungal susceptibility testing of Candida haemulonii complex isolated from clinical samples.Folia microbiologica · 2024Article
- Development of Echinocandin Resistance inJournal of fungi (Basel, Switzerland) · 2023Article
- Candida haemulonii complex, an emerging threat from tropical regions?PLoS neglected tropical diseases · 2023Review
- Article
- Review
- The Threat CalledJournal of fungi (Basel, Switzerland) · 2022Article
- Phenotypic Switching and Filamentation in Candida haemulonii, an Emerging Opportunistic Pathogen of Humans.Microbiology spectrum · 2021Article
- Article
- Insights into the Multi-Azole Resistance Profile inJournal of fungi (Basel, Switzerland) · 2020Article
- Susceptibility of theJournal of fungi (Basel, Switzerland) · 2020Article
- Increasing Prevalence of Multidrug-ResistantJournal of fungi (Basel, Switzerland) · 2020Article
- Pathogenicity Levels of Colombian Strains ofJournal of fungi (Basel, Switzerland) · 2020Article
- First Genome Sequences of Two Multidrug-ResistantFrontiers in microbiology · 2020Article
- Article
- Article
- Molecular identification and antifungal susceptibility pattern ofCurrent medical mycology · 2019Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report 3 cases of patients with Candida haemulonii isolates that were obtained from hemocultures. In 2 of the 3 cases, isolates exhibited resistance to echinocandins and fluconazole. This is the first report of an echinocandin-resistant species of this fungus in pediatric patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.